Pharmacist Check-Ins may cut cancer Patients' emergency trips

NCT ID NCT06469957

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a hospital pharmacist's interview could reduce unplanned doctor visits or hospital stays for adults with lung cancer receiving chemotherapy, immunotherapy, or oral targeted therapy. Researchers tracked 60 patients over six months, counting unscheduled consultations and hospitalizations. The goal was to see if pharmacist involvement improves medication management and reduces disruptions in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHOPULMONARY CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU d'Orléans

    Orléans, 45067, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.